BAP vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Credicorp Ltd. (BAP) shows a mixed financial profile with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score to assess distress risk. Profitability metrics are strong, including a 31.62% profit margin and 18.55% ROE, while revenue and earnings growth remain solid at 15.5% and 14.2% YoY, respectively. However, the stock trades above its Graham Number of $269.56 at $344.33, and technical trends are bearish with a score of 10/100. Analysts recommend a 'buy' with a target price below current levels, suggesting limited upside.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BAP vs JPM: Head-to-Head Comparison
This page compares Credicorp Ltd. (BAP) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.